Evidence map›Paper›PMID 30948204›Full record

ReviewTrends in cognitive sciences2019

Can't or Won't? Immunometabolic Constraints on Dopaminergic Drive.

Michael T Treadway, Jessica A Cooper, Andrew H Miller

Abstract readReview
In one paragraph

Review in Trends in cognitive sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Synaptic effects of interleukin-6 on human iPSC-derived dopaminergic neurons.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Neuroimmune pathophysiology of long COVID.Psychiatry and clinical neurosciences · 2025
    Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael T TreadwayDepartment of Psychology, Emory University, Atlanta, GA 30322, USA; Department of Psychiatry and Behavioral Sciences and The Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: mtreadway@emory.edu.
Jessica A CooperDepartment of Psychology, Emory University, Atlanta, GA 30322, USA.
Andrew H MillerDepartment of Psychiatry and Behavioral Sciences and The Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Phenotyping Major Depression with Increased InflammationR01MH087604 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2010 to 2014
$2.2M
Dynamics of Inflammation and its Blockade on Motivational Circuitry in DepressionR01MH108605 · NIMH · EMORY UNIVERSITY · PI TREADWAY, MICHAEL TILGHMAN · 2016 to 2020
$2.1M
Inflammation-Induced CNS Glutamate Changes in DepressionR01MH112076 · NIMH · EMORY UNIVERSITY · PI HAROON, EBRAHIM, MILLER, ANDREW H · 2016 to 2020
$2.0M
Dopaminergic Mechanisms of Cytokine-Induced Behavioral ChangeR01MH083746 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2009 to 2012
$1.5M
Inflammation-Induced CNS Glutamate During Breast Cancer TreatmentR21MH105897 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2015 to 2016
$429k
Motivational anhedonia: neurocomputational mechanisms and temporal dynamicsF32MH115692 · NIMH · EMORY UNIVERSITY · PI ROBINSON, JESSICA COOPER · 2018 to 2021
$218k
NCATS NIH HHS UL1 TR000454NCI NIH HHS P30 CA138292NIMH NIH HHS F32 MH115692NIMH NIH HHS R01 MH083746NIMH NIH HHS R01 MH087604NIMH NIH HHS R01 MH108605NIMH NIH HHS R01 MH112076NIMH NIH HHS R21 MH105897
6 · The paper itself

Abstract

Inflammatory cytokines have been shown to have a direct effect on mesolimbic dopamine (DA) that is associated with a reduced willingness to expend effort for reward. To date, however, the broader implications of this communication between inflammation and mesolimbic DA have yet to be explored. Here, we suggest that the metabolic demands of chronic low-grade inflammation induce a reduction of striatal DA that in turn leads to a steeper effort-discounting curve because of reduced perceived ability (can't) versus preference (won't) for reward. This theoretical framework can inform how the mesolimbic DA system responds to increased immunometabolic demands during chronic inflammation, ultimately contributing to motivational impairments in psychiatric and other medical disorders.

Indexed as

AnimalsDopaminergic NeuronsEnergy MetabolismHumansInflammationLimbic Systemcytokinesdopamineeffortimmunometabolisminflammation

Identifiers

PMID30948204
PMCPMC6839942

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.